I Agree

We have updated our Privacy and Cookie Policy. By clicking "I Agree" below, you acknowledge that you accept our Privacy and Cookie Policy and Terms of Use.

PLEASE TELL US A LITTLE ABOUT YOURSELF SO THAT WE CAN DISPLAY THE MOST
APPROPRIATE CONTENT TO YOU:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies used on Trustnet and how you can manage them, see our Privacy and Cookie Policy.

By clicking "I Agree" below, you acknowledge that you accept our Privacy Policy and Terms of Use.

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
You are here: MAXCYTE (DI) COM STK USD0.01 (DI) MXCT Announcements

MAXCYTE (DI) COM STK USD0.01 (DI) (MXCT) Announcements

Date Time Source Announcement
08 Jul 2020 7:00 am
RNS
APEIRON Biologics Clinical and Commercial License
  7:00 am
RNS
APEIRON Biologics Clinical and Commercial License
01 Jul 2020 7:00 am
RNS
Block Listing Return & TVR
  7:00 am
RNS
Block Listing Return & TVR
02 Jun 2020 5:54 pm
RNS
Holding(s) in Company
  5:54 pm
RNS
Holding(s) in Company
28 May 2020 3:34 pm
RNS
Holding(s) in Company
  3:34 pm
RNS
Holding(s) in Company
26 May 2020 5:49 pm
RNS
Holding(s) in Company
  5:49 pm
RNS
Holding(s) in Company
  4:22 pm
RNS
Holding(s) in Company
  4:22 pm
RNS
Holding(s) in Company
  3:45 pm
RNS
Holdings in Company
  3:45 pm
RNS
Holdings in Company
21 May 2020 1:50 pm
RNS
Result of Special Meeting and Issue of Equity
  1:50 pm
RNS
Result of Special Meeting and Issue of Equity
14 May 2020 7:00 am
RNS
Poster Presentation on MCY-M11 at ASCO 2020
  7:00 am
RNS
Poster Presentation on MCY-M11 at ASCO 2020
07 May 2020 7:00 am
RNS
License Agreement with Caribou Biosciences
  7:00 am
RNS
License Agreement with Caribou Biosciences
01 May 2020 7:00 am
RNS
Result of Offering
  7:00 am
RNS
Result of Offering
30 Apr 2020 5:39 pm
RNS
Proposed Offering to raise up to �25.1 million
  5:39 pm
RNS
Proposed Offering to raise up to �25.1 million
21 Apr 2020 7:00 am
RNS
Final Results for Year Ended 31 December 2019
  7:00 am
RNS
Final Results for Year Ended 31 December 2019
09 Apr 2020 7:00 am
RNS
Business Update Related to COVID-19 Pandemic
  7:00 am
RNS
Business Update Related to COVID-19 Pandemic
24 Mar 2020 7:00 am
RNS
License Agreement with Allogene Therapeutics
  7:00 am
RNS
License Agreement with Allogene Therapeutics
21 Feb 2020 7:00 am
RNS
Consolidation of Trading Lines
  7:00 am
RNS
Consolidation of Trading Lines
20 Feb 2020 6:18 pm
RNS
AIM Block Admission Return / Total Voting Rights
  6:18 pm
RNS
AIM Block Admission Return / Total Voting Rights
05 Feb 2020 7:00 am
RNS
MaxCyte to Present at BIO CEO & Investor Conf
24 Jan 2020 4:31 pm
RNS
Grant Of Options
  4:31 pm
RNS
Grant Of Options
22 Jan 2020 5:15 pm
RNS
Holding(s) in Company
  5:15 pm
RNS
Holding(s) in Company
  5:15 pm
RNS
Holding(s) in Company
  5:11 pm
RNS
Holding(s) in Company
  5:11 pm
RNS
Holding(s) in Company
  5:11 pm
RNS
Holding(s) in Company
  5:08 pm
RNS
Holding(s) in Company
  5:08 pm
RNS
Holding(s) in Company
20 Jan 2020 7:00 am
RNS
Trading Update
  7:00 am
RNS
Trading Update
19 Dec 2019 7:00 am
RNS
New Executive Vice President and Trial Update
  7:00 am
RNS
New Executive Vice President and Trial Update
16 Dec 2019 5:25 pm
RNS
Director/PCA transaction initial notification
  5:25 pm
RNS
Director/PCA transaction initial notification
04 Dec 2019 7:00 am
RNS
Agreement with KSQ Therapeutics
  7:00 am
RNS
Agreement with KSQ Therapeutics
21 Nov 2019 7:00 am
RNS
Vor Biopharma Clinical and Commercial License
  7:00 am
RNS
Vor Biopharma Clinical and Commercial License
14 Nov 2019 7:00 am
RNS
Presentation at Jefferies Healthcare Conference
07 Nov 2019 7:00 am
RNS
MaxCyte to Present at BIO-Europe 2019
01 Nov 2019 1:04 pm
RNS
Result of AGM
  1:04 pm
RNS
Result of AGM
24 Oct 2019 7:00 am
RNS
MaxCyte Advances Phase I Clinical Trial
Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close